Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 82

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 82
---
 fees and/or penalties for          
 previous non-compliance with relevant licensing requirements, which could adversely affect its results of operation. Additionally,           
 in extreme case, NewGenIvf may need to cease operations until it is able to obtain appropriate licensure, which may adversely affect         
 its revenue for a period of time that it cannot estimate.                                                                                    |

<div align='center'>45</div>

| ● | Patients’ Right                                                                                                                        
 Protection. There has been an increased awareness of patients’ rights in Thailand, Cambodia and Kyrgyzstan, especially                 
 with the issuance of the Constitution of the Kingdom of Thailand, the Act on Court Proceedings for Consumer Cases B.E. 2551 (2008) (as 
 amended), National Health Act B.E. 2550 (2007), and other applicable laws in Thailand, the Civil Code dated December 8, 2017           
 as amended by the Law on Implementation of the Civil Code dated May 31, 2011, Law on Management of Donation and Transplantation        
 of Human Cells, Tissues, and Organs (2016) and Sub-Decree No. 61 on the Code of Medical Ethics (2003) in Cambodia and Constitution     
 of Kyrgyzstan of May 5, 2021, Civil Code, Part I of May 8, 1996 No. 15, Law on Health Protection of Civilians of Kyrgyzstan            
 of January 9, 2005 No. 6, Law on Reproduction Rights and on Guarantees of their Realization of July 4, 2015 No. 148, Law               
 on status of medical worker of May 28, 2013 No. 81 and other relevant applicable laws in Kyrgyzstan, which enables consumers and       
 patients to file suits more easily against healthcare service providers. Furthermore, treatment of more complex medical conditions     
 has no guaranteed positive outcome, which subjects it to an increased likelihood of medical malpractice suits. Such lawsuits could     
 result in hefty compensation payments or damage to NewGenIvf’s reputation, which may have a material adverse effect on its             
 business, financial condition, results of operations and prospects.                                                                    |

Meanwhile, Thailand is considering
enacting a Patient Protection Bill (the “Bill”). The Bill, if issued, is intended to alleviate disputes between patients
and healthcare providers, which have an impact on the healthcare system in Thailand as a whole. The compensation outlined in the Bill
will assist patients in claiming damages, thereby fostering a positive relationship between patients